Revolution Medicines, Inc. · NASDAQ:RVMD

Anders Jack sold 35,750 Revolution Medicines, Inc. shares (Form 4)

Traded Nov 11, 2026 · Filed Nov 13, 2026

On Nov 11, 2026, Anders Jack (Chief Financial Officer) sold 35,750 Revolution Medicines, Inc. shares at an average US$188.10 for US$6.72M under a trading plan, leaving 119,216 shares. Filed Nov 13, 2026 (Form 4).

Sold
35,750 shares
Price
US$188.10 average (US$181.04 to US$192.84)
Value
US$6.72M
Holding after
119,216 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 11, 2026Common StockOption exercise15,900US$42.45135,116Direct
Nov 11, 2026Common StockOption exercise19,850US$18.56154,966Direct
Nov 11, 2026Common StockSale3,499US$181.04151,467Direct
Nov 11, 2026Common StockSale5,776US$182.09145,691Direct
Nov 11, 2026Common StockSale2,700US$182.87142,991Direct
Nov 11, 2026Common StockSale1,900US$184.02141,091Direct
Nov 11, 2026Common StockSale800US$185.04140,291Direct
Nov 11, 2026Common StockSale400US$186.41139,891Direct
Nov 11, 2026Common StockSale600US$187.34139,291Direct
Nov 11, 2026Common StockSale200US$189.17139,091Direct
Nov 11, 2026Common StockSale500US$190.99138,591Direct
Nov 11, 2026Common StockSale9,486US$191.94129,105Direct
Nov 11, 2026Common StockSale9,889US$192.84119,216Direct

Source

Download original · View original at SEC

Related